Kronz J D, Allan C H, Shaikh A A, Epstein J I
Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland 21231, USA.
Am J Surg Pathol. 2001 Aug;25(8):1079-85. doi: 10.1097/00000478-200108000-00014.
Most studies on the risk of cancer after high-grade prostatic intraepithelial neoplasia (PIN) on biopsy have been small (fewer than 100 men), have not analyzed in detail if histologic features can predict cancer, and have not assessed the risk of cancer with multiple repeat biopsies. We analyzed 245 men in whom the only abnormal finding on the initial biopsy was high-grade PIN and who had at least one follow-up biopsy. Repeat biopsy identified cancer in 32.2% of men. If only one follow-up biopsy had been performed on the 245 men, only 24.5% of men would have been found to have cancer. The only independent histologic predictor of a cancer diagnosis was the number of cores with high-grade PIN; risk of cancer: 30.2% with 1 or 2 cores, 40% with 3 cores, and 75% with >3 cores. The following did not predict cancer: number of high-grade PIN glands, maximum percentage of gland involved by high-grade PIN, nucleolar prominence, percentage of cells with prominent nucleoli, pattern of high-grade PIN (flat, tufting, micropapillary, cribriform), marked pleomorphism, digital rectal examination, transrectal ultrasound findings, family history of prostate cancer, serum prostate specific antigen (PSA) at time of high-grade PIN diagnosis, and rate of change of serum PSA. Eighty-one (33%) men had more than one follow-up biopsy; in these cases the following findings on the original high-grade PIN biopsy predicted cancer: the presence of mitoses, the number of positive cores, predominant micropapillary and cribriform high-grade PIN, and very large prominent nucleoli. Of 81 men with more than one follow-up biopsy, if the first repeat biopsy were benign, high-grade PIN, or atypical, the eventual cancer rate was 10%, 25.9%, and 57.1%, respectively (p = 0.002). Of 15 men with more than two repeat biopsies, only two (13.3%) had cancer. In summary, approximately one third of men with high-grade PIN on biopsy have cancer on follow-up. If cancer is not found on the first two follow-up biopsies, it will unlikely be found. Although clinical findings at the time of diagnosis of high-grade PIN are not useful to predict who might have cancer, histologic findings may help identify who needs additional biopsies.
大多数关于活检发现高级别前列腺上皮内瘤变(PIN)后癌症风险的研究规模较小(男性少于100例),未详细分析组织学特征是否可预测癌症,也未评估多次重复活检后的癌症风险。我们分析了245例男性,这些男性初次活检的唯一异常发现是高级别PIN,且至少进行了一次随访活检。重复活检发现32.2%的男性患有癌症。如果仅对这245例男性进行一次随访活检,仅24.5%的男性会被发现患有癌症。癌症诊断的唯一独立组织学预测因素是存在高级别PIN的活检芯数;癌症风险:1或2个芯时为30.2%,3个芯时为40%,超过3个芯时为75%。以下因素不能预测癌症:高级别PIN腺泡数量、高级别PIN累及腺泡的最大百分比、核仁突出程度、核仁突出细胞的百分比、高级别PIN的模式(扁平、簇状、微乳头状、筛状)、明显多形性、直肠指检、经直肠超声检查结果、前列腺癌家族史、高级别PIN诊断时的血清前列腺特异性抗原(PSA)以及血清PSA的变化率。81例(33%)男性进行了不止一次随访活检;在这些病例中,初次高级别PIN活检的以下发现可预测癌症:有丝分裂的存在、阳性活检芯数、主要为微乳头状和筛状的高级别PIN以及非常大的突出核仁。在81例进行了不止一次随访活检的男性中,如果首次重复活检为良性、高级别PIN或非典型,最终癌症发生率分别为10%、25.9%和57.1%(p = 0.002)。在15例进行了两次以上重复活检的男性中,只有2例(13.3%)患有癌症。总之,活检发现高级别PIN的男性中约三分之一在随访时有癌症。如果在前两次随访活检中未发现癌症,则不太可能发现癌症。虽然高级别PIN诊断时的临床发现对预测谁可能患有癌症无用,但组织学发现可能有助于确定谁需要额外的活检。